U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878560) titled 'Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients with ESRD' on March 03.
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of the 10 GE Xenokidney in patients with ESRD who are either not eligible for conventional allogeneic kidney transplantation (Group 1) or are on an Organ Procurement and Transplantation Network (OPTN) kidney transplant waitlist, but are more likely to die or go untransplanted within 5 years than receive a kidney transplant (Group 2).
The study consists of xenotransplantation followed by a 24 week Post transplant Follow up Period (Part A) to evaluate th...